Discovery and Development of Non-Covalent, Reversible Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC-0853)
2019 ◽
Vol 1586
◽
pp. 106-115
◽
2018 ◽
Vol 15
(11)
◽
pp. 5124-5134
◽
2018 ◽
Vol 22
(8)
◽
pp. 978-990
◽
2020 ◽
Vol 80
◽
pp. 106215
◽
2018 ◽
Vol 103
(6)
◽
pp. 1020-1028
◽
2019 ◽
Vol 143
(2)
◽
pp. AB144
◽